Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation for Benign and Malignant Pulmonary Ground-glass Nodules Based on MRI Dynamic Contrast Enhanced Imaging

NCT05067023 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.

NCT NCT05067023
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05067023 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation for Benign and Malignant Pulmonary Ground-glass Nodules Based on MRI Dynamic Contrast Enhanced Imaging
Lead sponsor
Qianfoshan Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
November 20, 2021
Completion date
March 15, 2023
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary nodules